The Effect of Music Applied During Chemotherapy on Anxiety and Satisfaction Levels

Sponsor
Uludag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05687838
Collaborator
(none)
90
1
3
12
7.5

Study Details

Study Description

Brief Summary

Chemotherapy is a treatment that uses natural or synthetic chemicals and biological agents to kill rapidly proliferating cells. As chemotherapeutic drugs prevent the growth and proliferation of cancer cells, they also inhibit the growth of normal cells such as intestinal and oral mucosal epithelium, bone marrow cells, and hair follicle cells. During chemotherapy treatment, which is widely used in the treatment of cancer cases and considered one of the most effective methods of cancer treatment, individuals; may experience side effects such as nausea-vomiting, loss of appetite, mouth ulcers, pain, fatigue, anxiety, depression, sleep problems, and changes in their skin and nails.

There are several factors that can trigger anxiety in cancer patients: fear of cancer and its treatment-related side effects, fear of relapse after treatment, uncertainty, concerns about changing roles and relationships, and fear of death. Treatment methods are available for a variety of side effects and negative effects experienced by cancer patients. These methods include pharmacological and nonpharmacological approaches. For example, benzodiazepines are frequently used to treat anxiety in cancer patients. If benzodiazepines are not adequate, low-dose antipsychotics can be used. However, benzodiazepines and their derivatives may reduce respiratory function, induce sedation, and cause confusion.

Music is an example of non-pharmacological cognitive-behavioral treatment that is used to control negative symptoms in many fields. The use of music for healing is easy, has no side effects, and is beneficial for physical, psychological, emotional, and spiritual well-being. Anxiety and fear can be reduced by therapeutic music, which increases endorphin secretion and positive emotions. Treatment of serious illnesses such as cancer requires a holistic approach that includes psychological, social, and spiritual support in addition to pharmacological treatment. Therefore, the purpose of this study is to examine how different types of music affect cancer patients' anxiety and satisfaction during chemotherapy.

Condition or Disease Intervention/Treatment Phase
  • Other: Music
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Two Different Types of Music Applied During Chemotherapy on Anxiety and Satisfaction Levels
Actual Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Relaxing Music Group

The patients in this group will listen to specially composed "MusiCure®" compositions, which contain melodies with soft rhythm (60-80 bpm), including harp, cello, strings, and nature sounds (such as rain, bird, forest sound). The patients scheduled to receive chemotherapy for the first time, will be allowed to listen to music for at least one hour during chemotherapy with over-ear headphones (Sennheiser HD280) and an MP3 player. Anxiety and satisfaction levels of the patients will be recorded before and after the music application.

Other: Music
Music medicine

Active Comparator: Turkish Makam Music Group

The patients in this group will listen to the "Rast Makam", which was created as a result of research conducted by the Turkish Music Research and Promotion Group (TÜMATA) and provides individuals with comfort and inner peace. The patients scheduled to receive chemotherapy for the first time, will be allowed to listen to music for at least one hour during chemotherapy with over-ear headphones (Sennheiser HD280) and an MP3 player. Anxiety and satisfaction levels of the patients will be recorded before and after the music application.

Other: Music
Music medicine

No Intervention: Control Group

The patients in this group will not receive any musical interventions and will receive standard treatment and care during chemotherapy.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline Anxiety level [baseline, 60-120 minute]

    Baseline and post-intervention anxiety level assessed by trained research nurse using Spielberg's State-Trait Anxiety Inventory (STAI). The test scores between 20 and 80, with higher scores indicating more generalized and stronger anxiety.

Secondary Outcome Measures

  1. Satisfaction level [60-120 minute]

    Post-intervention satisfaction level assessed by trained research nurse using VAS (0 to 10; 0 means not satisfied, 10 means very satisfied).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years old,

  • Receiving chemotherapy for the first time.

Exclusion Criteria:
  • Hearing or vision problems,

  • Have a lower education level than secondary school (The STAI is appropriate for those who have at least a sixth-grade reading level),

  • Diagnosed with psychiatric and neurological diseases,

  • Diagnosed with dementia,

  • Received chemotherapy treatment more than once,

  • Planned to receive radiotherapy treatment together with chemotherapy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bursa Uludag University Faculty of Medicine Hospital, The Outpatient Chemotherapy Unit Bursa Turkey 16059

Sponsors and Collaborators

  • Uludag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Öznur ERBAY DALLI, Asst. Prof., Uludag University
ClinicalTrials.gov Identifier:
NCT05687838
Other Study ID Numbers:
  • 2022-13/18
First Posted:
Jan 18, 2023
Last Update Posted:
Jan 18, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Öznur ERBAY DALLI, Asst. Prof., Uludag University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2023